These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27147623)
1. Analytical performance specifications for changes in assay bias (Δbias) for data with logarithmic distributions as assessed by effects on reference change values. Petersen PH; Lund F; Fraser CG; Sölétormos G Ann Clin Biochem; 2016 Nov; 53(6):686-691. PubMed ID: 27147623 [TBL] [Abstract][Full Text] [Related]
2. Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals. Hyltoft Petersen P; Lund F; Fraser CG; Sandberg S; Sölétormos G Ann Clin Biochem; 2018 Sep; 55(5):612-615. PubMed ID: 29310466 [TBL] [Abstract][Full Text] [Related]
3. Combination of analytical quality specifications based on biological within- and between-subject variation. Petersen PH; Fraser CG; Jørgensen L; Brandslund I; Stahl M; Gowans E; Libeer JC; Ricós C Ann Clin Biochem; 2002 Nov; 39(Pt 6):543-50. PubMed ID: 12564835 [TBL] [Abstract][Full Text] [Related]
4. Analytical goals for the estimation of non-Gaussian reference intervals. Hyltoft Petersen P; Gowans EM; Blaabjerg O; Hørder M Scand J Clin Lab Invest; 1989 Dec; 49(8):727-37. PubMed ID: 2617130 [TBL] [Abstract][Full Text] [Related]
5. Analytical quality specifications for common reference intervals. Ricós C; Doménech MV; Perich C Clin Chem Lab Med; 2004; 42(7):858-62. PubMed ID: 15327023 [TBL] [Abstract][Full Text] [Related]
6. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits". Hyltoft Petersen P; Klee GG Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109 [TBL] [Abstract][Full Text] [Related]
7. Moving standard deviation and moving sum of outliers as quality tools for monitoring analytical precision. Liu J; Tan CH; Badrick T; Loh TP Clin Biochem; 2018 Feb; 52():112-116. PubMed ID: 29107011 [TBL] [Abstract][Full Text] [Related]
8. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art. Haeckel R; Wosniok W Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158 [TBL] [Abstract][Full Text] [Related]
9. Tolerance limits for short-term analytical bias and analytical imprecision derived from clinical assay specificity. Klee GG Clin Chem; 1993 Jul; 39(7):1514-8. PubMed ID: 8330413 [TBL] [Abstract][Full Text] [Related]
10. Different percentages of false-positive results obtained using five methods for the calculation of reference change values based on simulated normal and ln-normal distributions of data. Lund F; Petersen PH; Fraser CG; Sölétormos G Ann Clin Biochem; 2016 Nov; 53(6):692-698. PubMed ID: 27151961 [TBL] [Abstract][Full Text] [Related]
16. Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Blackwell S; O'Reilly DS; Talwar D Eur J Clin Invest; 2007 May; 37(5):364-71. PubMed ID: 17461982 [TBL] [Abstract][Full Text] [Related]
19. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications. Petersen PH; Jensen EA; Brandslund I Clin Chem Lab Med; 2011 Dec; 50(5):819-31. PubMed ID: 22628319 [TBL] [Abstract][Full Text] [Related]
20. Indirect derivation of biological variation data and analytical performance specifications for therapeutic drug monitoring activities. Chai JH; Flatman R; Teis B; Sethi SK; Badrick T; Loh TP Pathology; 2019 Apr; 51(3):281-285. PubMed ID: 30803737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]